TRUE Private Wealth Advisors Grows Stock Position in Colgate-Palmolive (NYSE:CL)

TRUE Private Wealth Advisors lifted its stake in Colgate-Palmolive (NYSE:CL) by 59.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 4,939 shares of the company’s stock after purchasing an additional 1,839 shares during the quarter. TRUE Private Wealth Advisors’ holdings in Colgate-Palmolive were worth $394,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. OFI Invest Asset Management acquired a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth increased its stake in Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in Colgate-Palmolive during the fourth quarter worth $34,000. Quarry LP increased its stake in Colgate-Palmolive by 48.2% during the second quarter. Quarry LP now owns 446 shares of the company’s stock worth $34,000 after acquiring an additional 145 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its stake in Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after acquiring an additional 291 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently commented on CL shares. Wells Fargo & Company raised their price target on Colgate-Palmolive from $80.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Monday, January 29th. Morgan Stanley lifted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, January 29th. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a report on Friday, January 26th. StockNews.com lowered Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, The Goldman Sachs Group began coverage on Colgate-Palmolive in a report on Friday, March 1st. They issued a “buy” rating and a $93.00 target price for the company. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $89.50.

Insiders Place Their Bets

In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the transaction, the executive vice president now owns 8,043 shares in the company, valued at approximately $686,470.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, EVP Gregory Malcolm sold 8,930 shares of the business’s stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now directly owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 232,371 shares of company stock worth $19,505,099. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 0.7 %

CL opened at $86.77 on Thursday. The business’s 50-day simple moving average is $86.97 and its 200-day simple moving average is $80.63. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37. The stock has a market capitalization of $71.32 billion, a P/E ratio of 31.21, a price-to-earnings-growth ratio of 3.24 and a beta of 0.42.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.77 EPS. Analysts anticipate that Colgate-Palmolive will post 3.49 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.30%. The ex-dividend date of this dividend is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is 69.06%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.